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1. Introduction
Gait analysis of patients with neurological disorders, including multiple sclerosis (MS), is impor-
tant for rehabilitation and treatment. In a clinical setting, gait analysis performed by physicians or
therapists involves observing a patient’s gait and manual documentation of subjective assessments.
Different clinical scores are proposed in order to quantify the level of progression of MS. Among
them the expanded disability status scale (EDSS) and the self-scored multiple sclerosis walking scale
(MSWS) are widely used in clinical practice [1,2]. However, these clinical scores are subjective and
are unable to detect subtle changes in a subject’s gait due to the progression of the disease or the
response to treatment. A more systematic gait analysis can be carried out in a gait laboratory
using motion capture systems, force-plates, and electromyography (EMG) sensors. However, the
required set up involves elaborate preparation and marker placement, rendering it unsuitable for
use as a point-of-care technology.
A number of indices based on time or distance characteristics of human gait cycle have been
proposed for objective gait assessment in neurological patients with gait abnormality. Specifically,
studies have shown that a shorter stride length and gait swing time and a higher double support
percentage in a gait cycle (i.e., the fraction of the time in a gait cycle where the two feet are on the
ground) are observed in neurological patients with gait abnormality [3–6]. In addition, the range
of the hip and knee angle is smaller in MS patients as compared to healthy individuals as reported
in [7,8]. Correlations between time-distance and joint angle indices and the EDSS score have been
investigated as well [5, 6, 9].
Angles of the lower extremity joints in a MS patient’s gait have also been investigated. However,
researchers have reported contradictory results. Specifically, reduced hip and knee flexion and ankle
plantarflexion at heel strike (i.e., the point in the gait cycle when foot reaches the ground), and hip
and knee extension at toe-off (i.e., the point in the gait cycle where foot is no longer in contact with
the ground) are reported in [9,10], while increased hip and knee flexion and ankle plantarflexion at
heel strike has been observed in [8]. The analysis in these studies involve point-to-point comparisons
between preselected peak points of the joint angles during a gait cycle.
Although accurate gait analysis for MS patients could provide valuable insight on a patient’s
condition and the progression of the disease, an easy-to-use system which can encourage clinical
adoption does not exist. Motion capture systems, which are mainly used for experimental data
collection for gait analysis, are expensive. Furthermore, motion capture systems can only track a
set of reflective markers mounted on certain anatomical landmarks of a patient’s body, and hence, its
use requires a time-consuming patient preparation process. Moreover, operator training for motion
capture systems is necessary to ensure acceptable accuracy. Finally, these systems are not portable
and require a dedicated space which makes them further impractical for clinical applications.
The Mircrosoft KinectR© sensor, which was developed for motion recognition in gaming appli-
cations, is an ideal candidate for an inexpensive system providing the capability for human gait
analysis. The Kinect sensor includes a color camera and a depth sensor, consisting of an infrared
projector and camera, and provides full-body 3D motion capture. The Kinect sensor has been
used for various clinical and non-clinical applications. The authors in [11] use the Kinect sensor for
pose identification. In [12], joint angles identified by the Kinect sensor are compared to the “gold
standard” obtained by a marker-based motion capture systems for healthy subjects, which showed
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reasonable accuracy for clinical applications. The validity of the Kinect sensor for the assessment
of the postural control was examined by comparing the result with the result of a marker-based
motion capture system too [13]. Also, the accuracy of this sensor for movement measurement in
people with neurological disease, such as Parkinson, has been examined [14].
However, a limited number of studies have been performed to investigate the feasibility of Kinect
specifically for gait analysis of MS patients [15–17]. In [17], the short maximum speed walk test
was proposed by the authors to be measured with Kinect, where the correlation of this index with
EDSS was investigated. Furthermore, based on machine learning and image processing techniques,
movements of MS patients were compared with healthy subjects to identify subgroups with similar
movement patterns [16]. Authors in [18] have developed a framework to identify MS patients from
healthy subjects by analyzing a number of tasks such as finger-to-nose and finger-to-finger tests.
In this research, we develop a framework to quantify the gait abnormality of MS patients using
a Kinect for Windows (version 1) camera. We show that previously introduced indices quantifying
gait abnormality as well as an index for quantifying a patient’s gait pattern introduced in this report
are in strong agreement with clinical scoring systems that quantify the degree of the progression of
the disease. Specifically, we show that there is a correlation between a number of gait indices and
the self-scored MSWS as well as the clinical ambulation score [1,2] when clinical data is obtained
using a Kinect camera. The clinical ambulation score, which is one of the required scores for
computing the EDSS score, is determined by a clinician through clinical observation of a patient’s
gait. Considering the clinical ambulation score appears to be more meaningful for patient gait
abnormality assessment compared to EDSS which quantifies a patient’s general disability due to
the MS disease and involves factors other than gait.
In this report, in addition to the previously introduced gait indices, a novel set of MS gait
indices based on the concept of dynamic time warping [19] is introduced. The newly introduced
indices can characterize a patient’s gait pattern as a whole (rather than considering isolated events
in a gait cycle), and quantify a subject’s gait “distance” from the healthy population. We will
investigate the correlation of these novel indices with the MSWS and the clinical ambulation score.
This work establishes the feasibility of using the Kinect sensor for clinical gait assessment for MS
patients.
2. Gait Analysis for MS Patients
2.1. Subjects
In this study, 10 male and female MS patients (9 females and 1 male), and 10 sex and age
matched healthy control subjects were asked to walk in front of the Kinect camera for 5-10 trials
(i.e., a video sequence which involves a subject moving in front of the camera on a straight line). The
best five captures were selected for the analysis. This study was approved by the Research Ethics
Board at the McGill University Health Center and was conducted at the Montreal Neurological
Institute. For each patient the MSWS and the clinical ambulation score were assigned by an on-site
physician on the day of the study. MS patient information and their clinical assessment scores are
summarized in Table 1, whereas Table 2 summarizes the information related to healthy control
subjects.
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Table 1: MS Subjects Specifications
Patient No. Sex Age Ambulation Score MSWS Height[cm] Weight[kg]
P1 F 53 6 89.6 146 55
P2 F 41 0 25 170 86
P3 M 79 5 47.9 169 91
P4 F 69 1 60.4 150 81
P5 F 75 5 72.9 157 89
P6 F 60 6 81 170 79
P7 F 55 4 83.3 168 81
P8 F 70 9 97.9 178 81
P9 F 53 6 75 174 59
P10 F 55 1 45.8 161 51
Table 2: Healthy Control Subjects Specifications
Control Subject No. Sex Age Height[cm] Weight[kg]
C1 F 53 160 81
C2 F 36 165 70
C3 M 80 185 135
C4 F 71 163 82
C5 F 72 159 50
C6 F 62 147 59
C7 F 57 170 63
C8 F 67 170 63
C9 F 50 168 69
C10 F 51 165 53
In each trial, subjects were asked to walk at a normal pace. They were instructed to start their
gait outside of the camera’s field of view in order to ensure that their normal walking patterns have
been established once they reach the capture zone. As the Kinect field of view is limited, depending
on the stride length of the subjects, one or multiple gait cycles might have been captured. The
stored information related to each subject was de-identified to ensure patient privacy. Depending
on the level of progression of the disease, patients may have walked with or without the use of
assistive devices. Normal subjects passed an interview with the on-site physician to ensure they
did not suffer from any gait abnormalities and do not possess any condition that could affect their
gait.
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2.2. Data Analysis
The Kinect for Windows sensor with the use of its software development kit (SDK) provides
three-dimensional skeletal data on 20 joint positions over time. For the lower extremity, these joints
consist of pelvis, knee, and ankle for each leg. Kinect captures the video up to 30 frames per second.
Joint positions are expressed in an inertial reference frame in which the y-axis is in the direction
of the runway, the z-axis is perpendicular to the ground, and the x-axis is mutually perpendicular
to both (see Figure 1).


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

Figure 1: Captured data and the identified joints using Microsoft Kinect. The left hip angle θLH and left
knee angle θLK are shown in the Figure as well.
The subject’s kinematic properties can be extracted using the value of the joint positions. Joint
angles, and if required, angular velocities and accelerations can be calculated based on the time-
history of the joint positions. The first step in the process involves identifying a complete gait cycle
in the captured data. This can be accomplished by considering ankle position variations over time.
A gait cycle starts with heel strike, implying that the ankle joint position is stationary (see THS in
Figure 2). At toe-off the leg starts to swing, and hence, the ankle position starts to change (see TTO
in Figure 2). Finally, the gait cycle terminates by the terminal swing in which the ankle position
comes to rest again (see TTS in Figure 2). The ankle joint position variation for a representative
subject is shown in Figure 2.
In order to distinguish an abnormal gait from normal, and potentially quantify its degree of
abnormality, appropriate gait indices need to be defined. Three categories of indices are defined for
gait analysis in this study; namely, time-distance indices, joint angle, which have been discussed
in the literature, and gait pattern, which is introduced in this report. Here, four time-distance
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Figure 2: Ankle joint position variation captured
for Patient 6 (Trial 5). Heel strike, toe-off and
terminal swing phases are denoted by THS, TTO,
and TTS, respectively.
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Figure 3: Hip angle variations for an MS patient
and a healthy control subject.
indices, namely, subject velocity, stride length, stance percentage, and stride width are considered
as suggested by authors in [3–5]. In the joint angle category, hip and knee range of motion is
considered due to the fact that studies show that MS can substantially affect these joints [7].
Finally, a novel index, which can capture the general gait pattern of the subject and its deviation
from a healthy gait, is introduced.
A subject’s velocity for one gait cycle can be calculated by dividing the stride length to the
gait cycle time (from THS to TTS). To be able to meaningfully compare distance indices, they
are normalized based on a subject’s height to compute normalized velocity Vn. Furthermore,
normalized stride length Ln, defined as the distance travelled by the ankle in one gait cycle (i.e.,
between the heel strike THS and the terminal swing phases TTS), stride width W, defined as the
distance between the two ankles in the double support phase projected on the x-axis, and stance
percentage S, defined as the ratio of the stance time to the gait cycle time, can be calculated.
Finally, the knee and hip angles need to be computed using the location of the joints. Knee angle
is defined as the angle between the thigh and the leg segments, and the hip angle is defined as the
angle between the z-axis and the thigh segment (see Figure 1).
2.2.1. Dynamic Time Warping
Although minimum/maximum joint angle values, range of motion, and time-distance indices
can provide valuable information on a subject’s gait characteristics, they only provide a snapshot
at a specific time instant. Developing a framework capable of analyzing a complete gait cycle (as
opposed to analyzing certain points in a gait cycle) provides a holistic approach for gait analysis
and can complement the information provided by other indices. This involves developing a distance
metric to quantify the level of abnormality of a gait cycle with respect to healthy individuals. There
have been prior attempts in comparing MS gait patterns with control subjects by point-to-point
comparisons at certain gait phases such as heel strike or toe-off [8–10]. However, no study has
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introduced a mechanism to compare complete gait cycles.
Here, we propose a set of novel MS gait indices based on the dynamic time warping (DTW)
framework. DTW, which was initially proposed for speech recognition applications [20], provides a
framework to find an optimal alignment between two time series that have different time scales. This
is ideal for comparing sequences representing the human gait cycle as any gait cycle includes the
same gait phases (i.e., heel strike, toe-off, etc.), however, the transition time between these phases
varies from subject to subject. DTW has been previously used in other non-clinical contexts
such as human motion recognition and in identifying different modes of movements and motion
patterns [21, 22]. DTW defines a cost function and uses a nonlinear transformation to warp the
two sequences in order to minimize the cost function. The optimal value of the cost function can
be regarded as a “distance measure” between the two sequences.
Let us consider two sequences A = {a1, a2, . . . , aN}, an ∈ R, n = 1, . . . , N , and B = {b1, b2, . . . ,
bM}, bm ∈ R, m = 1, . . . , M . A local distance cost between two elements of the sequence an ∈ A
and bm ∈ B is a mapping c : A× B → R+ such that c(an, bm) increases as the mismatch between
an and bm increases. Next, we define a cost matrix C = [cnm] ∈ R
N×M , where cnm = c(an, bm),
n = 1, . . . , N , m = 1, . . . ,M . A sequence p = {p1, p2, . . . , pL}, pl = (nl,ml), l = 1, . . . , L,
nl ∈ {1, . . . , N}, ml ∈ {1, . . . , M} is referred to as a warping path if it satisfies the boundary,
monotonicity, and step size conditions discussed in [19]. A warping path defines the point-to-point
correspondence between the two sequences. The total cost cp(A,B) for the two sequences A and
B along a warping path p is defined as
cp(A,B) :=
L∑
l=1
c(anl , bml), anl , bml ∈ p. (1)
Consider the set of all possible warping paths for the two sequences A and B denoted by P.
The dynamic time warping distance between A and B is defined
DTW(A,B) := cp∗(A,B), (2)
where p∗ := argminp∈Pcp(A,B) is the optimal warping path.
2.2.2. Dynamic Time Warping for Gait Analysis
Here, we investigate the application of DTW to quantify MS disease progression. Specifically, we
investigate its correlations with the MSWS and clinical ambulation score. The DTW framework can
be used to align two sequences, for instance unaligned hip angle variations over time for a patient
and a normal subject gait. Figure 3 shows the the two sequences for a representative patient and
a control subject. The value of the DTW distance defined in (2) shows the deviation of a patient’s
joint pattern from a normal subject. A larger DTW indicates a larger deviation between patient
and the healthy subject gait patterns, and potentially a more advanced stage of MS. In longitudinal
studies, all of these novel DTW distances could potentially show the progression of the MS disease
in a particular patient over time and provide insight on a patient’s response to treatments.
In this research, in order to evaluate a patient’s gait, we extract time series for hip and knee
angles for a complete gait cycle and compute the hip and knee DTW distances with respect to
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a set of control subjects. Note that maximum hip and knee flexion angles are reported to be
different in MS patients compared to healthy control subjects [8–10]. In this study, the goal is
to further investigate the relationship between the degree of gait abnormality and lower extremity
joint variations over a complete gait cycle and not limit the analysis to extreme joint angles.
The dataset included in this study is composed of gait data collected from np patients, where
each patient completed mp trials. In addition, the control dataset is composed of gait data col-
lected from nc control subjects, where each control subject completed mc trials. As discussed in
Section 2.2, for each trial, one complete gait cycle from heel strike to toe-off is identified and the rest
is discarded. Therefore, overall the dataset includes npmp gait cycles corresponding MS patients
and ncmc gait cycles corresponding to healthy control subjects. In our study, np = nc = 10 and
mp = mc = 5.
For each patient, hip joint angles for the left and right legs over the entire gait cycle are calcu-
lated and stored in arrays θLHi,j , θRHi,j , respectively, where i ∈ {1, . . . , np}, and j ∈ {1, . . . ,mp}.
Similarly, knee joint angles for the patient’s left and right legs are stored as θLKi,j , θRKi,j , respec-
tively, where i ∈ {1, . . . , np} and j ∈ {1, . . . ,mp}. For control subjects, hip and knee joint angles
for the left and right legs are calculated and stored in φLHq,r , φRHq,r , φLKq,r , φRKq,r , respectively,
where q ∈ {1, . . . , nc} and r ∈ {1, . . . ,mc}.
Here, we introduce an index referred to as the mean dynamic time warping distance. This
index quantifies the degree of dissimilarity between a patient’s joint angle pattern compared to a
set of control subjects. Specifically, the DTW distance between two time series, namely, a patient’s
joint angle for a given trial and a set of control subjects joint angles for all available trials are
computed. Note that these distances are computed for the left and right legs independently. That
is, a patient’s left (right) leg joint angle sequence is compared with all left (right) joint angle
sequences for all control subjects. Hence, overall ncmc DTW distances are computed for each leg
(in our case ncmc = 50).
Considering the fact thatmp trials are available for each patient, mpncmc = 250 DTW distances
are obtained for each patient’s leg and each joint. Hence, a total of 2mpncmp = 500 DTW distances
are computed for each joint (i.e, knee and hip). These distances are then averaged to compute
the mean dynamic time warping distance associated with the knee or hip joint for each patient.
Specifically, for Patient i, i ∈ {1, . . . , np}, the mean dynamic time warping distance for knee and
hip joints, denoted by DKP and DHP , respectively, are defined as
DKP :=
1
2
[
1
mpncmc
mp∑
j=1
nc∑
q=1
mc∑
r=1
DTW(θLKi,j ,φLKq,r) +
1
mpncmc
mp∑
j=1
nc∑
q=1
mc∑
r=1
DTW(θRKi,j ,φRKq,r)
]
,
(3)
DHP :=
1
2
[
1
mpncmc
mp∑
j=1
nc∑
q=1
mc∑
r=1
DTW(θLHi,j ,φLHq,r) +
1
mpncmc
mp∑
j=1
nc∑
q=1
mc∑
r=1
DTW(θRHi,j ,φRHq,r)
]
.
(4)
Similarly, the mean dynamic time warping distance associated with the knee and hip joints for
control subjects denoted byDKC andDHC , respectively, can be defined, where the distance between
joint sequences for a control subject is compared with all other control subjects.
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3. Results and Discussion
The aforementioned time-distance and joint angle indices discussed in previous literature, and
the newly introduced mean DTW indices associated with quantifying gait abnormality are com-
puted for all patients and control subjects. A list of all the computed indices is given in Table 3. The
mean value for each index (averaged over 5 trials) for patients and control subjects are summarized
in Tables 4 and 5, respectively.
The results are also illustrated in Figures 4-11 in form of box plots. The hip and knee posi-
tions for Patient 9 showed severe artifacts, and hence, this patient was excluded from the analysis
for indices involving hip and knee. Note that for MS patients, the median velocity and median
stride length are smaller compared to healthy control subjects (Figures 4 and 5), while the median
stance percentage, as well as the knee and hip ranges of motions are larger (Figures 6-9). These
observations are in agreement with previously reported gait characteristics of MS patients [3–8].
Furthermore, the newly introduced indices based on the DTW distance can provide further insight
on the general gait pattern. More specifically, the median hip and knee mean DTW distances in-
crease significantly in subjects with MS disease (Figures 10 and Figure 11). Larger DTW distances
imply that the patient’s gait pattern in the MS population is not “similar” to the healthy control
group.
Table 3: Gait Indices for MS Patients
Index Symbol Unit Description
Normalized velocity Vn sec
−1 Velocity normalized by hight
Normalized stride length Ln Unitless Stride length normalized by hight
Stance percentage S Unitless Stance time divided by gait cycle time
Step width W m Distance between the two ankles in double support phase projected on the x-axis
Hip range of motion αH deg Difference between minimum and maximum of the hip angle
Knee range of motion αK deg Difference between minimum and maximum of the knee angle
Mean dynamic time warping distance for knee DK deg See (3)
Mean dynamic time warping distance for hip DH deg See (4)
Table 4: Gait Indices for MS Patients
Patient Vn[s
−1] Ln S[%] W[m] αK [deg] αH [deg] DK[deg] DH[deg]
P1 0.48 0.44 66 0.68 36.0 17.9 191 182
P2 1.23 0.78 59 0.61 42.7 25.8 262 156
P3 0.82 0.67 58 0.59 35.5 22.0 275 178
P4 0.48 0.51 63 0.81 34.9 24.1 275 207
P5 0.64 0.58 61 0.84 30.9 23.1 285 155
P6 0.48 0.55 69 1.04 26.1 20.0 362 272
P7 0.73 0.67 58 1.02 34.2 26.7 265 178
P8 0.39 0.47 52 1.01 39.2 19.5 516 369
P9 0.56 0.59 54 0.83 27.3 32.1 293 178
P10 0.87 0.63 59 0.42 43.7 25.7 150 142
Next, we investigate the reliability of each index using the intraclass correlation coefficient
(ICC). Specifically, the ICC is calculated for both the patient and control groups. The results are
8
Table 5: Gait Indices for Control Subjects
Control Vn[s
−1] Ln S[%] W[m] αK [deg] αH [deg] DK[deg] DH[deg]
C1 1.35 0.78 45 0.64 42.9 19.3 161 155
C2 1.12 0.78 52 0.54 50.1 32.8 168 124
C3 1.12 0.73 53 0.95 33.8 26.9 206 123
C4 0.97 0.66 53 0.79 37.8 26.2 323 223
C5 1.38 0.90 48 0.41 50.5 32.8 160 114
C6 1.25 0.81 49 0.65 42.6 24.2 145 117
C7 1.19 0.80 48 0.58 52.7 30.6 164 123
C8 1.21 0.84 46 0.50 46.6 31.1 156 114
C9 1.16 0.71 54 0.31 43.5 27.2 195 140
C10 1.42 0.77 54 0.62 50.5 38.1 170 147
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Figure 5: Normalized stride length Ln
for patients and control subjects.
given in Tables 6 and 7. As it can be seen in both groups all indices have acceptable intraclass
correlations with the exception of step width in MS patients. Also, the knee range of motion index
possess a wide confidence interval. In order to statistically compare the differences between the
value of indices corresponding to the patient and control groups, the paired t-test was used (see
Tables 6 and 7). All indices show statistically significant difference between the patient and control
groups as signified by small p-values (p ≤ 0.05).
Finally, we note that all considered indices with the exception of stance percentage, and hip
range of motion show a high degree of correlation with the clinical ambulation score and MSWS.
The stride width shows an acceptable degree of correlation with MSWS but not with the ambulation
score. This observations signify the fact that the Kinect sensor can provide an objective framework
for assessing gait abnormality that can be of clinical utility. The data can provide invaluable insight
on the progression of the disease and response to treatment.
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Table 6: Statistics for time-distance-derived indices
Vn[s−1] Ln S[%] W[m]
MS Mean (SD) 0.4 (0.14) 0.6 (0.1) 0.6 (0.05) 0.8 (0.2)
Control Mean (SD) 1.2 (0.14) 0.8 (0.07) 0.5 (0.03) 0.6 (0.18)
MS ICC (95% CI) 0.99 (0.984,0.998) 0.93 (0.83,98) 0.71 (0.25,0.92) 0.50 (0.63,0.96)
Control ICC (95% CI) 0.93 (0.84,0.98) 0.90 (0.76,0.97) 0.75 (0.38,0.93) 0.80 (0.52,0.95)
Correlation Ambulation Score (95% CI) -0.69 (-0.81,-0.50) 0.54 (0.30,0.71) -0.14 (-0.40,0.15) 0.43 (0.17,0.64)
Correlation with MSWS (95% CI) -0.86 (-0.91,-0.76) 0.69 (0.50,81) 0.04 (-0.24,0.33) 0.51 (0.26,0.70)
t-test p-value 10−6 10−4 10−4 0.044
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Table 7: Statistics for angle-derived indices
αK [deg] αH [deg] DK[deg] DH[deg]
MS Mean (SD) 36 (5) 23 (3) 236 (68) 210 (47)
Control Mean (SD) 47 (9) 30 (4) 191 (54) 156 (36)
MS ICC (95% CI) 0.61 (-0.01,0.90) 0.92 (0.80,0.98) 0.88 (0.69,0.97) 0.78 (0.43,0.94)
Control ICC (95% CI) 0.89 (0.74,0.97) 0.98 (0.94,0.99) 0.93 (0.82,0.97) 0.82 (0.54,0.94)
Correlation Ambulation Score (95% CI) -0.42 (-0.64,-0.14) -0.63 (-0.78,-0.41) 0.66 (0.44,0.80) 0.66 (0.45,0.80)
Correlation with MSWS (95% CI) -0.50 (-0.70,-0.24) -0.42 (-0.64,-0.14) 0.64 (0.41,0.79) 0.62 (0.39,0.77)
t-test p-value 0.0229 0.0067 0.0142 0.0026
11
References
[1] J. C. Hobart, A. Riazi, D. L. Lamping, R. Fitzpatrick, and A. J. Thompson, “Measuring the
impact of ms on walking ability: the 12-item ms walking scale (MSWS-12),” Neurology, vol. 60,
pp. 31–36, 2003.
[2] J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis,” Neurology, vol. 33, no. 11,
p. 1444, 1983.
[3] M. K. Holden, K. M. Gill, and M. R. Magliozzi, “Gait assessment for neurologically impaired
patients,” Phys. Therapy, vol. 66, pp. 1530–1539, 1986.
[4] J. G. Remelius, J. Hamill, J. Kent-Braun, and R. E. A. Van Emmerik, “Gait initiation in
multiple sclerosis,” Motor Control, vol. 12, no. 2, pp. 93–108, 2008.
[5] R. Sacco, R. Bussman, P. Oesch, J. Kesselring, and S. Beer, “Assessment of gait parameters
and fatigue in ms patients during inpatient rehabilitation: A pilot trial,” J. Neurology, vol.
258, no. 5, pp. 889–894, 2011.
[6] U. Givon, G. Zeilig, and A. Achiron, “Gait analysis in multiple sclerosis: Characterization
of temporalspatial parameters using gaitrite functional ambulation system,” Gait & Posture,
vol. 29, pp. 138–142, 2009.
[7] G. Gehlsen, K. Beekman, N. Assmann, D. Winant, M. Seidle, and A. Carter, “Gait character-
istics in multiple sclerosis: Progressive changes and effects of exercise on parameters,” Arch.
Phys. Med. Rehab., vol. 67, pp. 536–539, 1986.
[8] M. G. Benedetti, R. Piperno, L. Simoncini, P. Bonato, A. Tonini, and S. Giannini, “Gait
abnormalities in minimally impaired multiple sclerosis patients,” Mult. Sclerosis J., vol. 5,
no. 5, pp. 363–368, 1999.
[9] J. M. Huisinga, K. K. Schmid, M. Filipi, and S. N., “Gait mechanics are different between
healthy controls and patients with multiple sclerosis,” J. Appl. Biomech., vol. 29, pp. 303–311,
2013.
[10] K. J. Kelleher, W. Spence, S. Solomonidis, and D. Apatsidis, “The characterisation of gait
patterns of people with multiple sclerosis,” Disab. Rehab., vol. 32, no. 15, pp. 1242–1250,
2010.
[11] J. Shotton, T. Sharp, A. Kipman, M. Fitzgibbon, A. Finocchio, A. Blake, and M. Cook, “Real-
time human pose recognition in parts from a single depth image,” in IEEE Conf. Comp. Vis.
Patt. Recog., 2011, pp. 1297–1304.
[12] A. Fernan´dez-Baena, A. Susin, and X. Lligadas, “Biomechanical validation of upper-body
and lower-body joint movements of kinect motion capture data for rehabilitation treatments,”
Proc. Int. Conf. Intell. Networking Collab. Syst., pp. 656–661, 2012.
[13] R. A. Clark, Y. Pua, K. Fortin, C. Ritchie, K. E. Webster, L. Denehy, and A. L. Bryant,
“Validity of the microsoft kinect for assessment of postural control,” Gait & Posture, vol. 36,
pp. 372–377, 2012.
[14] B. Galna, G. Barry, D. Jackson, D. Mhiripiri, P. Olivier, and L. Rochester, “Accuracy of the
microsoft kinect sensor for measuring movement in people with parkinsons disease,” Gait &
Posture, vol. 39, pp. 1062–1068, 2014.
[15] C. Pfu¨eller, K. Otte, S. Mansow-Model, F. Paul, and A. Brandt, “Kinect-based analysis of
posture, gait and coordination in multiple sclerosis patients,” Neurology, vol. 80, 2013.
[16] M. D. Souza, C. Kamm, J. Burggraaff, P. Tewarie, B. Glocker, J. Dorn, T. Vogel, C. Morrison,
A. Sellen, M. Machacek, P. Chin, B. Uitdehaag, A. Criminisi, F. Dahlke, C. Polman, and
L. Kappos, “Assessment of disability in multiple sclerosis using the Kinect-camera system: A
proof-of-concept study,” Neurology, vol. 82, no. 10, p. 139, 2014.
[17] B. J., C. Pfu¨ller, S. Mansow-Model, K. Otte, F. Paul, and A. U. Brandt, “Using perceptive
computing in multiple sclerosis - the short maximum speed walk test,” J. Neuroeng. Rehab.,
vol. 11, no. 1, p. 89, 2014.
[18] P. Kontschieder, J. F. Dorn, C. Morrison, R. Corish, D. Zikic, A. Sellen, M. DSouza, C. P.
Kamm, J. Burggraaff, P. Tewarie, T. Vogel, M. Azzarito, B. Glocker, P. Chin, F. Dahlke,
C. Polman, L. Kappos, B. Uitdehaag, and A. Criminisi, “Quantifying progression of multi-
ple sclerosis via classification of depth videos,” Med. Image Comput. Comput. Assist. Interv.
(MICCAI), vol. 17, no. 2, pp. 429–437, 2014.
[19] M. Mu¨ller, “Dynamic time warping,” in Information Retrieval for Music and Motion, 2007,
pp. 69–84.
[20] L. R. Rabiner and B. H. Juang, Fundamentals of Speech Recognition. Prentice Hall Signal
Processing Series, 1993.
[21] A. Veeraraghavan, A. K. Roy-Chowdhury, and R. Chellappa, “Matching shape sequences in
video with applications in human movement analysis,” IEEE Trans. Patt. Anal. Mach. Intell.,
vol. 27, no. 12, pp. 1896–1909, 2005.
[22] J. Blackburn and E. Ribeiro, “Human motion recognition using isomap and dynamic time
warping,” in Human Motion: Understanding, Modeling, Capture and Animation, Lecture Notes
in Computer Science, Rio de Janeiro, Brazil, 2007, vol. 27, no. 4814, pp. 285–298.
